MIM
Monashee Investment Management Portfolio holdings
AUM
$190M
This Quarter Return
+12.54%
1 Year Return
+42.84%
3 Year Return
+185.9%
5 Year Return
+237.5%
10 Year Return
+2,730.86%
AUM
$567M
AUM Growth
+$567M
(+137%)
Cap. Flow
+$334M
Cap. Flow
% of AUM
58.98%
Top 10 Holdings %
Top 10 Hldgs %
88.03%
Holding
104
New
29
Increased
3
Reduced
10
Closed
60
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$119M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$118M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
$74.2M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
$55M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$38.8M |
Top Sells
| 1 |
Structure Therapeutics
GPCR
|
$18M |
| 2 |
Arm
ARM
|
$11.8M |
| 3 |
Seagate
STX
|
$7.58M |
| 4 |
Alight
ALIT
|
$6.79M |
| 5 |
Maplebear
CART
|
$6.07M |
Sector Composition
| 1 | Healthcare | 9.08% |
| 2 | Utilities | 1.25% |
| 3 | Industrials | 1.19% |
| 4 | Energy | 0.8% |
| 5 | Financials | 0.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShares Core S&P 500 ETF
IVV
$662B
| $119M | 20.97% | +248,710 | New | +$119M |
|
|
2
Vanguard S&P 500 ETF
VOO
$726B
| $118M | 20.89% | +271,010 | New | +$118M |
|
|
3
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $74.2M | 13.1% | +1,549,700 | New | +$74.2M |
|
|
4
iShares Core MSCI EAFE ETF
IEFA
$150B
| $55M | 9.72% | +782,380 | New | +$55M |
|
|
5
Vanguard FTSE Emerging Markets ETF
VWO
$96.4B
| $38.8M | 6.84% | +942,960 | New | +$38.8M |
|
6
iShares Core MSCI Emerging Markets ETF
IEMG
$102B
| $33.4M | 5.9% | +660,700 | New | +$33.4M |
|
7
iShares Core S&P Total US Stock Market ETF
ITOT
$75.2B
| $22.8M | 4.03% | +216,860 | New | +$22.8M |
|
8
Vanguard Total Stock Market ETF
VTI
$526B
| $22.8M | 4.02% | +96,060 | New | +$22.8M |
|
|
9
Structure Therapeutics
GPCR
$1.11B
| $7.82M | 1.38% | 191,855 -441,911 | -70% | -$18M |
|
10
AerCap
AER
$22B
| $6.69M | 1.18% | 90,000 +30,000 | +50% | +$2.23M |
|
11
PG&E
PCG
$33.6B
| $4.69M | 0.83% | +260,000 | New | +$4.69M |
|
12
Korro Bio
KRRO
$217M
| $4.35M | 0.77% | +90,805 | New | +$4.35M |
|
13
EyePoint Pharmaceuticals
EYPT
$797M
| $4.04M | 0.71% | +175,000 | New | +$4.04M |
|
14
Celldex Therapeutics
CLDX
$1.47B
| $3.97M | 0.7% | +100,209 | New | +$3.97M |
|
15
Roivant Sciences
ROIV
$8.15B
| $3.93M | 0.69% | 350,000 -200,000 | -36% | -$2.25M |
|
16
argenx
ARGX
$43.6B
| $3.8M | 0.67% | 10,000 +2,500 | +33% | +$951K |
|
17
Las Vegas Sands
LVS
$39.6B
| $3.69M | 0.65% | +75,000 | New | +$3.69M |
|
18
Gossamer Bio
GOSS
$562M
| $3.16M | 0.56% | 3,459,854 -1,844,358 | -35% | -$1.68M |
|
|
AMAM
19
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $2.95M | 0.52% | 207,500 +137,500 | +196% | +$1.96M |
|
20
Immunovant
IMVT
$2.56B
| $2.95M | 0.52% | 70,000 -100,000 | -59% | -$4.21M |
|
|
SWTX
21
DELISTED
SpringWorks Therapeutics
SWTX
| $2.7M | 0.48% | +73,949 | New | +$2.7M |
|
22
Permian Resources
PR
$10B
| $2.39M | 0.42% | 175,900 -325,200 | -65% | -$4.42M |
|
23
Fluence Energy
FLNC
$969M
| $2.39M | 0.42% | +100,000 | New | +$2.39M |
|
24
Vaxcyte
PCVX
$4B
| $2.36M | 0.42% | +37,500 | New | +$2.36M |
|
25
Vesta Real Estate
VTMX
$2.32B
| $2.18M | 0.38% | +55,000 | New | +$2.18M |
|